Flavin adenine dinucleotide disodium salt（FAD-Na2）-84366-81-4

Founded in 2006 and based in Qiantang District, Hangzhou, Hangzhou Meiya Pharmaceutical Co., Ltd. manufactures active pharmaceutical ingredients, intermediates, and food and feed additives, with a focus on advanced intermediates and specialized reagents. The company established a marketing subsidiary in Shanghai in 2012 and a major production base in Hai'an in 2014 (with total investment exceeding RMB 300 million), listed on China's New Third Board in 2015 (stock code 833650), and saw its Hai'an facility recognized as a national high-tech enterprise in 2020 and a Jiangsu Province 'small giant enterprise' in 2021. Offering contract manufacturing (CMO) to customers across North America, Western and Eastern Europe, Australasia, Asia, and Central/South America, the company is known for its delivery speed, production capacity, broad product line, and quality service.